abstract |
The present invention falls within the field of medical chemistry, and in particular relates to an FGFR4 inhibitor as shown in formula II, a preparation method thereof, a pharmaceutical composition comprising the inhibitor, and the use of the inhibitor or the pharmaceutical composition as a therapeutic drug for tumours. |